Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
ClinicalTrials.gov study NCT05487391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04012606. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov study NCT05445778. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients
ClinicalTrials.gov study NCT03509246. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
ClinicalTrials.gov study NCT02853305. IPD Sharing: YES. Countries: 0. Publications: 4.
Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT00002894. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
ClinicalTrials.gov study NCT02539719. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC
ClinicalTrials.gov study NCT04846452. IPD Sharing: YES. Countries: 1. Publications: 6.
Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC.
ClinicalTrials.gov study NCT07009925. IPD Sharing: NO. Countries: 0. Publications: 12.
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01033292. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05872412. IPD Sharing: NO. Countries: 1. Publications: 10.
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
ClinicalTrials.gov study NCT02751918. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Canc
ClinicalTrials.gov study NCT05460000. IPD Sharing: YES. Countries: 6. Publications: 0.
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT03076554. IPD Sharing: YES. Countries: 1. Publications: 3.
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
ClinicalTrials.gov study NCT03556839. IPD Sharing: NO. Countries: 8. Publications: 3.
Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)
ClinicalTrials.gov study NCT02578680. IPD Sharing: YES. Countries: 0. Publications: 8.
Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04361370. IPD Sharing: NO. Countries: 1. Publications: 1.
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
ClinicalTrials.gov study NCT02107235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)
ClinicalTrials.gov study NCT02163720. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy
ClinicalTrials.gov study NCT05222971. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.